Table 1 Demographic features, comorbidities, and treatment status in both HCV patients post chemotherapy (cases) and HCV patients without cancer (controls)
Groups of HCV patients | Total N (%) 171(100%) | p-value | ||
|---|---|---|---|---|
Post chemotherapy N (%) 83 (48.5%) | Without cancer N (%) 88 (51.5%) | |||
Gender | ||||
Female | 44 (53%) | 45 (51.1%) | 89 (52%) | 0.806 |
Male | 39 (47%) | 43 (48.9%) | 82 (48%) | |
Age/years | ||||
Mean ± SD | 52 ± 14 | 51 ± 13 | 0.660 | |
BMI | ||||
Mean ± SD | 29 ± 5 | 30 ± 6 | 0.406 | |
Treatment status | ||||
Treatment experienced | 15 (18.1%) | 13 (14.8%) | 28 (16.4%) | 0.560 |
Tobacco consumption | 5 (6%) | 2 (2.3%) | 7 (4.1%) | 0.216 |
Hypertension | 5 (6%) | 6 (6.8%) | 11 (6.4%) | 0.35 |
DM | 20 (24.1%) | 13 (14.8%) | 33 (19.3%) | 0.123 |